Abstract
Background
Several previous studies have revealed that the Glasgow Prognostic Score (GPS) is a clinically useful scoring system to predict the prognosis of patients with various kinds of advanced cancers. However, there have been few reports on the relationship between the GPS and prognosis after hepatectomy for hepatocellular carcinoma (HCC). Therefore, we performed an analysis of the relationship between the GPS and prognosis after hepatectomy for HCC.
Methods
Between January 2005 and December 2009, 352 HCC patients underwent hepatectomy at Kumamoto University Hospital. Nineteen clinicopathologic factors were analyzed, using univariate and multivariate analyses.
Results
Univariate analysis showed that significant risk factors for poor survival included serum albumin level (<3.5 g/dL), tumor size (>35 mm), presence of ascites, portal vein invasion, operation time (>400 min), blood loss (>360 mL), requirement for blood transfusion, and GPS. Multivariate analysis revealed that tumor size [hazard ratio (HR) 3.355; p = 0.003], operation time (HR 2.634; p = 0.006), portal vein invasion (HR 2.419; p = 0.009), and GPS (HR 3.796; p < 0.001) were independent factors for poor prognosis.
Conclusion
The GPS was demonstrated to be a statistically significant prognostic factor after hepatectomy for HCC.
Similar content being viewed by others
Abbreviations
- GPS:
-
Glasgow Prognostic Score
- HCC:
-
Hepatocellular carcinoma
- Vp:
-
Portal vein invasion
- Vv:
-
Hepatic vein invasion
- HR:
-
Hazard ratio
- CRP:
-
C-reactive protein
- T-Bil:
-
Total bilirubin
- Alb:
-
Albumin
- PT:
-
Prothrombin
- ICG R15:
-
Indocyanine green retention rate at 15 min
- HBs-Ag:
-
Hepatitis B surface antigen
- HCV-Ab:
-
Hepatitis C virus antibody
- IL-6:
-
Interleukin-6
- hGPS:
-
Hepatic Glasgow Prognostic Score
References
Poon RT, Ng IO, Fan ST et al (2001) Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 19(12):3037–3044
Sumie S, Kuromatsu R, Okuda K et al (2008) Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15(5):1375–1382
Katz SC, Shia J, Liau KH et al (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249(4):617–623
Cho SY, Park SJ, Kim SH et al (2010) Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol 17(7):1823–1830
Ramacciato G, Nigri G, Bellagamba R et al (2010) Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg 76(11):1260–1268
Muratore A, Ribero D, Zimmitti G et al (2010) Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 17(5):1324–1329
Pathak S, Tang JM, Terlizzo M et al (2010) Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases. Eur J Surg Oncol 36(1):52–57
Masuda T, Beppu T, Horino K et al (2010) Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma. J Surg Oncol 102(5):490–496
Arii S, Tanaka J, Yamazoe Y et al (1992) Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 69(4):913–919
Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649
Haider M, Haider SQ (1984) Assessment of protein-calorie malnutrition. Clin Chem 30(8):1286–1299
Forrest LM, McMillan DC, McArdle CS et al (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89(6):1028–1030
Forrest LM, McMillan DC, McArdle CS et al (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90(9):1704–1706
Ishizuka M, Nagata H, Takagi K et al (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246(6):1047–1051
Kobayashi T, Teruya M, Kishiki T et al (2010) Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival. Dig Surg 27(4):285–290
Al Murri AM, Bartlett JM, Canney PA et al (2006) Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94(2):227–230
Vashist YK, Loos J, Dedow J et al (2011) Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer. Ann Surg Oncol 18(4):1130–1138
Shimoda M, Katoh M, Kita J et al (2010) The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer. Chemotherapy 56(6):501–506
Fujiwara Y, Shiba H, Furukawa K et al (2010) Glasgow prognostic score is related to blood transfusion requirements and post-operative complications in hepatic resection for hepatocellular carcinoma. Anticancer Res 30(12):5129–5136
Ishizuka M, Kubota K, Kita J et al (2011) Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma. J Surg Oncol 103(8):801–806
Su CH, Tsay SH, Wu CC et al (1996) Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223(4):384–394
Ueno S, Tanabe G, Nuruki K et al (2002) Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepatobiliary Pancreat Surg 9(4):469–477
Ichikawa T, Uenishi T, Takemura S et al (2009) A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 16(1):42–48
McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67(3):257–262
Ji J, Shi J, Budhu A et al (2009) MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361(15):1437–1447
Conflict of interest
The authors declare that they have no conflict interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Horino, K., Beppu, T., Kuroki, H. et al. Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma. Int J Clin Oncol 18, 829–838 (2013). https://doi.org/10.1007/s10147-012-0451-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-012-0451-3